{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:10:42Z","timestamp":1785381042787,"version":"3.55.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.brainres.2024.149415","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T17:56:42Z","timestamp":1734717402000},"page":"149415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: Implications for multiple sclerosis"],"prefix":"10.1016","volume":"1853","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-8595","authenticated-orcid":false,"given":"Marie","family":"Kupjetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-0705","authenticated-orcid":false,"given":"Tiffany Y.","family":"Wences Chirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-8746","authenticated-orcid":false,"given":"Niklas","family":"Joisten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-4503","authenticated-orcid":false,"given":"Philipp","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0010","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1038\/s41598-019-40713-4","article-title":"Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate","volume":"9","author":"Aharoni","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bcp.2012.12.014","article-title":"Kynurenic acid as an antagonist of \u03b17 nicotinic acetylcholine receptors in the brain: Facts and challenges","volume":"85","author":"Albuquerque","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00213-011-2539-2","article-title":"Acute elevations of brain kynurenic acid impair cognitive flexibility: Normalization by the alpha7 positive modulator galantamine","volume":"220","author":"Alexander","year":"2012","journal-title":"Psychopharmacology (berl)"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.11.055","article-title":"Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum","volume":"159","author":"Amori","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2024.149415_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"International Journal of Tryptophan Research : IJTR"},{"key":"10.1016\/j.brainres.2024.149415_b0035","doi-asserted-by":"crossref","unstructured":"Bakker, L., Choe, K., Eussen, S.J.P.M., Ramakers, I.H.G.B., van den Hove, D.L.A., Kenis, G., Rutten, B.P.F., Verhey, F.R.J., K\u00f6hler, S., 2024. Relation of the kynurenine pathway with normal age: A systematic review. Mech Ageing Dev, Mechanisms of Ageing and Development 217, 111890.","DOI":"10.1016\/j.mad.2023.111890"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.psychres.2014.02.014","article-title":"Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder","volume":"216","author":"Bakkour","year":"2014","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/13524585221137697","article-title":"Serum NfL but not GFAP predicts cognitive decline in active progressive multiple sclerosis patients","volume":"29","author":"Barro","year":"2023","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00415-011-6147-1","article-title":"Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis","volume":"259","author":"Batista","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.brainres.2024.149415_b0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2014.02.019","article-title":"Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex","volume":"82","author":"Beggiato","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","article-title":"Minimal neuropsychological assessment of MS patients: A consensus approach","volume":"16","author":"Benedict","year":"2002","journal-title":"Clin. Neuropsychol."},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0065","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1177\/1352458513478675","article-title":"Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients","volume":"19","author":"Benedict","year":"2013","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues","volume":"19","author":"Benedict","year":"2020","journal-title":"The Lancet. Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","article-title":"Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: Evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry","volume":"61","author":"Beninger","year":"1994","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0080","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: A retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"The Lancet. Neurology"},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0085","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1177\/1352458515616204","article-title":"Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients","volume":"22","author":"Bergsland","year":"2016","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11682-016-9667-6","article-title":"Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume","volume":"12","author":"Bisecco","year":"2018","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/135245850100700409","article-title":"The brief repeatable battery of neuropsychological tests: Normative values allow application in multiple sclerosis clinical practice","volume":"7","author":"Boringa","year":"2001","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0100","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J. Immuno. (Baltimore, Md. : 1950)"},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0105","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12640-016-9657-x","article-title":"Characterization of the Kynurenine Pathway in CD8+ Human Primary Monocyte-Derived Dendritic Cells","volume":"30","author":"Braidy","year":"2016","journal-title":"Neurotox. Res."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10865-010-9247-y","article-title":"Treatment adherence in multiple sclerosis: Association with emotional status, personality, and cognition","volume":"33","author":"Bruce","year":"2010","journal-title":"J. Behav. Med."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(02)00392-0","article-title":"Apoptosis of oligodendrocytes in secondary cultures from neonatal rat brains","volume":"327","author":"Cammer","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2024.149415_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2021.01.018","article-title":"Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis","volume":"123","author":"Cao","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0125","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1046\/j.0953-816x.2001.01592.x","article-title":"Presynaptic kynurenate-sensitive receptors inhibit glutamate release","volume":"13","author":"Carpenedo","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0130","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1038\/s41598-021-89335-9","article-title":"Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder","volume":"11","author":"Cathomas","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2024.149415_b0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2018.10.010","article-title":"Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice","volume":"97","author":"Cauwels","year":"2019","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00415-012-6805-y","article-title":"Mr imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms","volume":"260","author":"Cerasa","year":"2013","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0145","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-019-1567-4","article-title":"Plasma neurofilament light chain and amyloid-\u03b2 are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease","volume":"16","author":"Chatterjee","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jnc.15128","article-title":"Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults","volume":"159","author":"Chatterjee","year":"2021","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41398-021-01587-1","article-title":"Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression","volume":"11","author":"Chen","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0170","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/pcn.13337","article-title":"Cross disorder comparisons of brain structure in schizophrenia, bipolar disorder, major depressive disorder, and 22q11.2 deletion syndrome: A review of ENIGMA findings","volume":"76","author":"Cheon","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0175","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbr.2006.03.006","article-title":"Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding","volume":"170","author":"Chess","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbr.2009.03.013","article-title":"L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning","volume":"201","author":"Chess","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0190","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/npp.2016.66","article-title":"Tryptophan Metabolism and White Matter Integrity in Schizophrenia","volume":"41","author":"Chiappelli","year":"2016","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.brainres.2024.149415_b0195","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0200","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","article-title":"Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis","volume":"102","author":"Chiarugi","year":"2001","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0205","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1471-4159.2001.00335.x","article-title":"Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid","volume":"77","author":"Chiarugi","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2024.149415_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2020.100126","article-title":"Kynurenine pathway metabolites selectively associate with impaired associative memory function in depression","volume":"8","author":"Chirico","year":"2020","journal-title":"Brain, Behavior, & Immunity - Health"},{"key":"10.1016\/j.brainres.2024.149415_b0215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jorganchem.2015.01.005","article-title":"Iron chelation and redox chemistry of anthranilic acid and 3-hydroxyanthranilic acid: A comparison of two structurally related kynurenine pathway metabolites to obtain improved insights into their potential role in neurological disease development","volume":"782","author":"Chobot","year":"2015","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.brainres.2024.149415_b0220","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.msard.2018.09.018","article-title":"How does cognition relate to employment in multiple sclerosis? A systematic review","volume":"26","author":"Clemens","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(92)90852-Z","article-title":"Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage","volume":"599","author":"Cockhill","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2024.149415_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.09.034","article-title":"The Janus faces of 3-hydroxykynurenine: Dual redox modulatory activity and lack of neurotoxicity in the rat striatum","volume":"1589","author":"Col\u00edn-Gonz\u00e1lez","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2024.149415_b0235","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.euroneuro.2021.11.003","article-title":"Selective association of cytokine levels and kynurenine\/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression","volume":"55","author":"Comai","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2008.06.007","article-title":"Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-gamma?","volume":"441","author":"Connor","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2024.149415_b0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"International Journal of Tryptophan Research : IJTR"},{"issue":"9","key":"10.1016\/j.brainres.2024.149415_b0255","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainres.2024.149415_b0260","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jad.2017.11.040","article-title":"A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls","volume":"227","author":"DeWitt","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0265","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41583-018-0053-9","article-title":"Multiple sclerosis and cognition: Synaptic failure and network dysfunction","volume":"19","author":"Di Filippo","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2024.149415_b0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.22337","article-title":"Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients","volume":"69","author":"Dutta","year":"2011","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0280","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.biopsych.2016.12.011","article-title":"Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders","volume":"82","author":"Erhardt","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149415_b0285","article-title":"Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review","volume":"13","author":"Fathi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2024.149415_b0290","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic Acid Activates mGlu2\/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci. Rep."},{"issue":"Pt B","key":"10.1016\/j.brainres.2024.149415_b0295","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","article-title":"Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors","volume":"112","author":"Fazio","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2024.149415_b0300","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3389\/fphar.2019.01044","article-title":"Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice","volume":"10","author":"Fertan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149415_b0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2017.09.021","article-title":"Brain mapping in multiple sclerosis: Lessons learned about the human brain","volume":"190","author":"Filippi","year":"2019","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0310","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.1985.tb05435.x","article-title":"Quinolinic acid phosphoribosyltransferase in rat brain","volume":"44","author":"Foster","year":"1985","journal-title":"J. Neurochem."},{"issue":"6\u20137","key":"10.1016\/j.brainres.2024.149415_b0315","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0531-5565(00)00172-8","article-title":"The network and the remodeling theories of aging: Historical background and new perspectives","volume":"35","author":"Franceschi","year":"2000","journal-title":"Exp. Gerontol."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0320","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-\u03b3-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0325","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: Implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pnpbp.2009.09.015","article-title":"The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study","volume":"34","author":"Gabbay","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0335","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1352458517695470","article-title":"The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis","volume":"24","author":"Golan","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.brainres.2024.149415_b0340","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.msard.2018.01.015","article-title":"Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis","volume":"20","author":"Gon\u00e7alves","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.brainres.2024.149415_b0345","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3389\/fneur.2019.01128","article-title":"Money Management in Multiple Sclerosis: The Role of Cognitive, Motor, and Affective Factors","volume":"10","author":"Goverover","year":"2019","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0350","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/sj.bjp.0706914","article-title":"Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain","volume":"149","author":"Grilli","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0355","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","article-title":"3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum","volume":"11","author":"Guidetti","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0360","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0365","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0370","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","article-title":"Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus","volume":"31","author":"Guillemin","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.brainres.2024.149415_b0375","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: Potential role in AIDS dementia complex","volume":"2","author":"Guillemin","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer's disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0385","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","article-title":"Kynurenine metabolism in multiple sclerosis","volume":"112","author":"Hartai","year":"2005","journal-title":"Acta Neurol. Scand."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0390","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000520152","article-title":"The Role of Kynurenines in Cognitive Dysfunction in Bipolar Disorder","volume":"81","author":"Hebbrecht","year":"2022","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.brainres.2024.149415_b0395","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2015.06.022","article-title":"Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory","volume":"50","author":"Heisler","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2024.149415_b0400","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3389\/fpsyg.2017.01561","article-title":"The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance","volume":"8","author":"Hestad","year":"2017","journal-title":"Front. Psychol."},{"issue":"19","key":"10.1016\/j.brainres.2024.149415_b0405","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","article-title":"The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: Physiopathological implications","volume":"21","author":"Hilmas","year":"2001","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.brainres.2024.149415_b0410","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1212\/01.wnl.0000276992.17011.b5","article-title":"Thalamic atrophy and cognition in multiple sclerosis","volume":"69","author":"Houtchens","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2024.149415_b0415","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/NDT.S239763","article-title":"Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention\/Vigilance and Social Cognition in Patients with Schizophrenia","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1191\/1352458505ms1127oa","article-title":"Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden","volume":"11","author":"Huang","year":"2005","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0425","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41398-021-01311-z","article-title":"Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia","volume":"11","author":"Huang","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0430","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11910-018-0809-7","article-title":"Sleep Disturbance and Cognitive Dysfunction in Multiple Sclerosis: a Systematic Review","volume":"18","author":"Hughes","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.brainres.2024.149415_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104898","article-title":"Relationship of tryptophan metabolites with the type and severity of multiple sclerosis","volume":"77","author":"Is\u0131k","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.brainres.2024.149415_b0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-\u03b2 and tau","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2024.149415_b0445","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01345272","article-title":"Role of zinc in blockade of excitotoxic action of quinolinic acid by picolinic acid","volume":"14","author":"Jhamandas","year":"1998","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0450","article-title":"Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis","volume":"8","author":"Joisten","year":"2021","journal-title":"Neurology(r) Neuroimmunology & Neuroinflammation"},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131389","article-title":"Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease","volume":"10","author":"Jones","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12929-021-00742-6","article-title":"Inflammatory signaling mechanisms in bipolar disorder","volume":"28","author":"Jones","year":"2021","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0465","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ebmental-2020-300207","article-title":"Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis","volume":"24","author":"Joseph","year":"2021","journal-title":"Evid. Based Ment. Health"},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0470","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1037\/0894-4105.22.4.442","article-title":"The relationship between cognitive deficits and everyday functional activities in multiple sclerosis","volume":"22","author":"Kalmar","year":"2008","journal-title":"Neuropsychology"},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0475","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/pcn.13373","article-title":"Left DLPFC activity is associated with plasma kynurenine levels and can predict treatment response to escitalopram in major depressive disorder","volume":"76","author":"Kamishikiryo","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0480","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(96)13216-X","article-title":"Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent","volume":"220","author":"Kelly","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0485","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1038\/s41380-019-0401-9","article-title":"Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia","volume":"25","author":"Kindler","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00702-002-0770-z","article-title":"Kynurenate production by cultured human astrocytes","volume":"110","author":"Kiss","year":"2003","journal-title":"J. Neural Trans. (Vienna, Austria : 1996)"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0495","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J. Neurochem."},{"issue":"32","key":"10.1016\/j.brainres.2024.149415_b0500","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1523\/JNEUROSCI.1107-14.2014","article-title":"Reduction of brain kynurenic acid improves cognitive function","volume":"34","author":"Kozak","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0505","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: Role of hemeoxygenase-1","volume":"179","author":"Krause","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2024.149415_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104592","article-title":"The serum kynurenine pathway metabolic profile is associated with overweight and obesity in multiple sclerosis","volume":"72","author":"Kupjetz","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12743","article-title":"Effect of apigenin on tryptophan metabolic key enzymes expression in lipopolysaccharide-induced microglial cells and its mechanism","volume":"9","author":"Kurniati","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0520","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-170447","article-title":"Novel Blood-Based Biomarkers of Cognition, Stress, and Physical or Cognitive Training in Older Adults at Risk of Dementia: Preliminary Evidence for a Role of BDNF, Irisin, and the Kynurenine Pathway","volume":"59","author":"K\u00fcster","year":"2017","journal-title":"Journal of Alzheimer's Disease : JAD"},{"issue":"12","key":"10.1016\/j.brainres.2024.149415_b0525","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"Ido expression in the brain: A double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J. Mol. Med. (berl)"},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0530","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0535","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458511431076","article-title":"Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)","volume":"18","author":"Langdon","year":"2012","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"key":"10.1016\/j.brainres.2024.149415_b0540","doi-asserted-by":"crossref","first-page":"36489","DOI":"10.1038\/srep36489","article-title":"Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticity","volume":"6","author":"Latif-Hernandez","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0545","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.intimp.2013.08.018","article-title":"The tryptophan metabolite 3-hydroxyanthranilic acid suppresses T cell responses by inhibiting dendritic cell activation","volume":"17","author":"Lee","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0550","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuint.2006.04.017","article-title":"In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain","volume":"50","author":"Leipnitz","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2024.149415_b0555","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fimmu.2020.01256","article-title":"Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis","volume":"11","author":"Lemos","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0560","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-023-06466-9","article-title":"Frontostriatal circuitry and the tryptophan kynurenine pathway in major psychiatric disorders","volume":"241","author":"Liang","year":"2024","journal-title":"Psychopharmacology (berl)"},{"key":"10.1016\/j.brainres.2024.149415_b0565","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2024.149415_b0570","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: An endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0575","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/schbul\/sbz111","article-title":"Transdiagnostic Dysfunctions in Brain Modules Across Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Connectome-Based Study","volume":"46","author":"Ma","year":"2020","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2024.149415_b0580","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2018.03.003","article-title":"Brain connectivity and cognitive processing speed in multiple sclerosis: A systematic review","volume":"388","author":"Manca","year":"2018","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing-Remitting Multiple Sclerosis","volume":"10","author":"Mancuso","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.brainres.2024.149415_b0590","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneurol.2015.222","article-title":"Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis","volume":"11","author":"Mandolesi","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0595","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41398-023-02555-7","article-title":"Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis","volume":"13","author":"Margoni","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0600","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1474-4422(10)70135-6","article-title":"Emerging effects of comorbidities on multiple sclerosis","volume":"9","author":"Marrie","year":"2010","journal-title":"The Lancet. Neurology"},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0605","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2024.149415_b0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0615","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/hbm.20692","article-title":"Corpus callosum damage and cognitive dysfunction in benign MS","volume":"30","author":"Mesaros","year":"2009","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0620","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/WNL.0b013e31827b910b","article-title":"The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects","volume":"80","author":"Minagar","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.brainres.2024.149415_b0625","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.1918215117","article-title":"Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation","volume":"117","author":"Mondanelli","year":"2020","journal-title":"PNAS"},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b0630","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s10072-020-04395-5","article-title":"Early putamen hypertrophy and ongoing hippocampus atrophy predict cognitive performance in the first ten years of relapsing-remitting multiple sclerosis","volume":"41","author":"Morelli","year":"2020","journal-title":"Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0635","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1177\/1352458517723991","article-title":"On-road assessment of fitness-to-drive in persons with MS with cognitive impairment: A prospective study","volume":"24","author":"Morrow","year":"2018","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0640","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrn1385","article-title":"Nmda receptors, place cells and hippocampal spatial memory","volume":"5","author":"Nakazawa","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0645","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/npp.2013.4","article-title":"Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors","volume":"38","author":"Neale","year":"2013","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0650","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.4049\/jimmunol.1601139","article-title":"Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis","volume":"198","author":"Negrotto","year":"2017","journal-title":"J. Immunol. (Baltimore, Md. : 1950)"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0655","article-title":"Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression. Brain","volume":"3","author":"Nho","year":"2021","journal-title":"Communications"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0660","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00702-005-0343-z","article-title":"Subchronic treatment with kynurenine and probenecid: Effects on prepulse inhibition and firing of midbrain dopamine neurons","volume":"113","author":"Nilsson","year":"2006","journal-title":"J. Neural Trans. (Vienna, Austria : 1996)"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0665","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11682-012-9170-7","article-title":"Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis","volume":"8","author":"Nocentini","year":"2014","journal-title":"Brain Imaging Behav."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0670","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbrc.2004.06.061","article-title":"3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression","volume":"320","author":"Oh","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.brainres.2024.149415_b0675","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.2147\/NDT.S279622","article-title":"Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Na\u00efve Major Depression: A Source-Based Morphometry Study","volume":"16","author":"Okamoto","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"22","key":"10.1016\/j.brainres.2024.149415_b0680","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.93.22.12553","article-title":"Hydrogen peroxide-mediated neuronal cell death induced by an endogenous neurotoxin, 3-hydroxykynurenine","volume":"93","author":"Okuda","year":"1996","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0685","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","article-title":"3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity","volume":"70","author":"Okuda","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2024.149415_b0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.09.010","article-title":"Lps-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning","volume":"313","author":"Oliveros","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0695","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.3233\/JAD-220906","article-title":"Tryptophan Metabolism and Neurodegeneration: Longitudinal Associations of Kynurenine Pathway Metabolites with Cognitive Performance and Plasma Alzheimer's Disease and Related Dementias Biomarkers in the Duke Physical Performance Across the LifeSpan Study","volume":"91","author":"Parker","year":"2023","journal-title":"Journal of Alzheimer's Disease : JAD"},{"key":"10.1016\/j.brainres.2024.149415_b0700","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neubiorev.2018.02.012","article-title":"The role of the cerebellum in multiple sclerosis-150 years after Charcot","volume":"89","author":"Parmar","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2024.149415_b0705","first-page":"116","article-title":"Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology","volume":"6","author":"Parrott","year":"2015","journal-title":"Front. Psych."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0710","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-016-0590-y","article-title":"Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge","volume":"13","author":"Parrott","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2024.149415_b0715","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2022.01.002","article-title":"Peripheral and central kynurenine pathway abnormalities in major depression","volume":"101","author":"Paul","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0720","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00894-015-2758-2","article-title":"Free-radical scavenging by tryptophan and its metabolites through electron transfer based processes","volume":"21","author":"P\u00e9rez-Gonz\u00e1lez","year":"2015","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.brainres.2024.149415_b0725","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919891169","article-title":"Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice","volume":"12","author":"Peyton","year":"2019","journal-title":"International Journal of Tryptophan Research : IJTR"},{"key":"10.1016\/j.brainres.2024.149415_b0730","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2017.04.015","article-title":"Tryptophan breakdown and cognition in bipolar disorder","volume":"81","author":"Platzer","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0735","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/npp.2011.127","article-title":"Fluctuations in endogenous kynurenic acid control hippocampal glutamate and memory","volume":"36","author":"Pocivavsek","year":"2011","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0740","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00406-016-0731-4","article-title":"Kynurenine pathway and white matter microstructure in bipolar disorder","volume":"268","author":"Poletti","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainres.2024.149415_b0745","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jad.2019.08.034","article-title":"Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder","volume":"259","author":"Poletti","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030945","article-title":"The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis","volume":"11","author":"Poly\u00e1k","year":"2023","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0755","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/npp.2010.39","article-title":"Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior","volume":"35","author":"Potter","year":"2010","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2024.149415_b0760","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.ircmb.2017.07.004","article-title":"Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer","volume":"336","author":"Prendergast","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2024.149415_b0765","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neulet.2006.03.051","article-title":"Kynurenic acid has a dual action on AMPA receptor responses","volume":"402","author":"Prescott","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0770","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1189\/jlb.3A0315-135R","article-title":"The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation","volume":"99","author":"Prodinger","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.brainres.2024.149415_b0775","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jpsychires.2019.03.027","article-title":"Elevated peripheral kynurenine\/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients","volume":"113","author":"Quagliato","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainres.2024.149415_b0780","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2371895","article-title":"3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture","volume":"2017","author":"Ram\u00edrez-Ortega","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2 Pt 1","key":"10.1016\/j.brainres.2024.149415_b0785","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1212\/WNL.39.2.161","article-title":"Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis","volume":"39","author":"Rao","year":"1989","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0790","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1471-4159.2005.03134.x","article-title":"Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum","volume":"93","author":"Rassoulpour","year":"2005","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0795","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","article-title":"Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis","volume":"114","author":"Rejdak","year":"2007","journal-title":"J. Neural Transmission (Vienna, Austria : 1996)"},{"key":"10.1016\/j.brainres.2024.149415_b0800","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuro.2015.08.003","article-title":"Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: Non-dependent-effect of early reactive oxygen species production","volume":"50","author":"Reyes-Ocampo","year":"2015","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0805","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1352458517743091","article-title":"Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis","volume":"25","author":"Riccitelli","year":"2019","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0810","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","article-title":"Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis","volume":"14","author":"Rocca","year":"2015","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0815","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1352458509102907","article-title":"Accumulation of cortical lesions in MS: Relation with cognitive impairment","volume":"15","author":"Roosendaal","year":"2009","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0820","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00415-012-6705-1","article-title":"Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: A 7-year longitudinal study","volume":"260","author":"Ruet","year":"2013","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2024.149415_b0825","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113423","article-title":"Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players","volume":"26","author":"Sandi","year":"2021","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.brainres.2024.149415_b0830","article-title":"Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: A systematic review of clinical studies","author":"Sapienza","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.brainres.2024.149415_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103667","article-title":"Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients","volume":"59","author":"Saraste","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.brainres.2024.149415_b0840","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psyneuen.2015.07.609","article-title":"Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder","volume":"62","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0845","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2024.149415_b0850","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","article-title":"Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder","volume":"52","author":"Savitz","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.brainres.2024.149415_b0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063250","article-title":"Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients","volume":"8","author":"Sbardella","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.brainres.2024.149415_b0860","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/WNL.0000000000001285","article-title":"Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis","volume":"84","author":"Schoonheim","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0865","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(83)90115-5","article-title":"Differential vulnerability of central neurons of the rat to quinolinic acid","volume":"38","author":"Schwarcz & K\u00f6hler","year":"1983","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.brainres.2024.149415_b0870","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: When physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 4","key":"10.1016\/j.brainres.2024.149415_b0875","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/brain\/awn030","article-title":"Regional hippocampal atrophy in multiple sclerosis","volume":"131","author":"Sicotte","year":"2008","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.brainres.2024.149415_b0880","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716980","article-title":"Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders","volume":"12","author":"Skorobogatov","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0885","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41386-021-01089-0","article-title":"Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia","volume":"47","author":"Smucny","year":"2022","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2024.149415_b0890","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbi.2018.10.003","article-title":"The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study","volume":"75","author":"Solvang","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2024.149415_b0895","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b0900","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2024.149415_b0905","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2024.149415_b0910","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12974-014-0204-5","article-title":"Quinolinic acid toxicity on oligodendroglial cells: Relevance for multiple sclerosis and therapeutic strategies","volume":"11","author":"Sundaram","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0915","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","article-title":"Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression","volume":"17","author":"Sundaram","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.brainres.2024.149415_b0920","doi-asserted-by":"crossref","unstructured":"Szalardy, L., Zadori, D., Toldi, J., Fulop, F., Klivenyi, P., Vecsei, L., 2012. Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Curr. Top. Med. Chem. 12 (16), 1797\u20131806.","DOI":"10.2174\/1568026611209061797"},{"key":"10.1016\/j.brainres.2024.149415_b0925","doi-asserted-by":"crossref","unstructured":"Taylor, M.W., Feng, G.S., 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J. 5 (11), 2516\u20132522.","DOI":"10.1096\/fasebj.5.11.1907934"},{"issue":"10130","key":"10.1016\/j.brainres.2024.149415_b0930","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.brainres.2024.149415_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113246","article-title":"A validated UHPLC-MS method for tryptophan metabolites: Application in the diagnosis of multiple sclerosis","volume":"185","author":"T\u00f6m\u00f6si","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0940","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ejn.14720","article-title":"Neuroinflammation and depression: A review","volume":"53","author":"Troubat","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b0945","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: Recent advances and new questions","volume":"12","author":"V\u00e9csei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainres.2024.149415_b0950","article-title":"Inflammatory Blood Biomarker Kynurenine Is Linked With Elevated Neuroinflammation and Neurodegeneration in Older Adults: Evidence From Two 1H-MRS Post-Processing Analysis Methods","volume":"13","author":"Vints","year":"2022","journal-title":"Front. Psych."},{"issue":"2","key":"10.1016\/j.brainres.2024.149415_b0955","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10072-015-2400-1","article-title":"Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: A systematic literature review","volume":"37","author":"Vollmer","year":"2016","journal-title":"Neurol. Sci."},{"issue":"9","key":"10.1016\/j.brainres.2024.149415_b0960","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"Nmda receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.brainres.2024.149415_b0965","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/MN:31:1-3:003","article-title":"Kainic acid-mediated excitotoxicity as a model for neurodegeneration","volume":"31","author":"Wang","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2024.149415_b0970","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jad.2022.08.108","article-title":"A combination of neuroimaging and plasma metabolomic analysis suggests inflammation is associated with white matter structural connectivity in major depressive disorder","volume":"318","author":"Wei","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0975","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0024-3205(87)90149-4","article-title":"Human macrophages degrade tryptophan upon induction by interferon-gamma","volume":"41","author":"Werner","year":"1987","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b0980","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13030490","article-title":"Oxidative Stress Biomarkers among Schizophrenia Inpatients","volume":"13","author":"Wi\u0119d\u0142ocha","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.brainres.2024.149415_b0985","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbi.2021.03.019","article-title":"Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathway","volume":"95","author":"Willette","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2024.149415_b0990","doi-asserted-by":"crossref","unstructured":"Woo, M. S., Engler, J. B., & Friese, M. A. (2024). The neuropathobiology of multiple sclerosis. Nature Reviews. Neuroscience. Advance online publication. https:\/\/doi.org\/10.1038\/s41583-024-00823-z.","DOI":"10.1038\/s41583-024-00823-z"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2024.149415_b0995","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12031-009-9235-2","article-title":"The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex","volume":"40","author":"Wu","year":"2010","journal-title":"Journal of Molecular Neuroscience : MN"},{"issue":"Suppl 2","key":"10.1016\/j.brainres.2024.149415_b1000","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/schbul\/sbt157","article-title":"Targeting kynurenine aminotransferase II in psychiatric diseases: Promising effects of an orally active enzyme inhibitor","volume":"40","author":"Wu","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b1005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1352458513496880","article-title":"The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients","volume":"20","author":"Yaldizli","year":"2014","journal-title":"Multiple Sclerosis (houndmills, Basingstoke, England)"},{"issue":"10","key":"10.1016\/j.brainres.2024.149415_b1010","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"Ido upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J. Immuno. (Baltimore, Md. : 1950)"},{"issue":"1","key":"10.1016\/j.brainres.2024.149415_b1015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3233\/JAD-140414","article-title":"The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer's disease","volume":"43","author":"Yu","year":"2015","journal-title":"Journal of Alzheimer's Disease : JAD"},{"issue":"12","key":"10.1016\/j.brainres.2024.149415_b1020","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s11064-020-03144-6","article-title":"Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice","volume":"45","author":"Zarzecki","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2024.149415_b1025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2022.07.011","article-title":"C-Reactive protein and the kynurenic acid to quinolinic acid ratio are independently associated with white matter integrity in major depressive disorder","volume":"105","author":"Zheng","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.brainres.2024.149415_b1030","article-title":"Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.brainres.2024.149415_b1035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.psyneuen.2018.11.001","article-title":"Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder","volume":"101","author":"Zhou","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.brainres.2024.149415_b1040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1460-9568.2008.06594.x","article-title":"Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release","volume":"29","author":"Zmarowski","year":"2009","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2024.149415_b1045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932400670X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932400670X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T01:06:55Z","timestamp":1741655215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689932400670X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":207,"alternative-id":["S000689932400670X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149415","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: Implications for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149415"}}